• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.

作者信息

Hasegawa Minoru, Sato Shinichi, Nagaoka Tetsuya, Fujimoto Manabu, Takehara Kazuhiko

机构信息

Department of Dermatology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan.

出版信息

Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783.

DOI:10.1159/000071783
PMID:12920362
Abstract

BACKGROUND

The enhanced production of some cytokines may be related to the pathogenesis of localized scleroderma (LSc).

OBJECTIVE

To determine whether serum levels of tumor necrosis factor (TNF) and interleukin (IL)-13 are elevated, and whether they correlated with clinical or serological features in patients with LSc.

METHODS

Serum levels of TNF and IL-13 were examined by ELISA in 45 patients with LSc and in 20 healthy controls.

RESULTS

The frequency of serum TNF detection was significantly higher in patients with LSc (24%) compared with that in healthy controls (0%). The frequency of serum IL-13 detection was also significantly higher in patients with LSc (29%) compared with that in controls (0%). In patients with LSc, elevated TNF levels significantly correlated with the presence of IgM antihistone antibodies, anti-single-stranded DNA antibodies, elevated serum IL-6 levels, the number of linear lesions, and muscle involvement. Elevated IL-13 levels were significantly associated with the number of plaque lesions and the total number of lesions.

CONCLUSIONS

These results suggest that TNF and IL-13 may be associated with the development of LSc.

摘要

相似文献

1
Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma.
Dermatology. 2003;207(2):141-7. doi: 10.1159/000071783.
2
Serum levels of soluble interleukin 6 receptor and soluble gp130 are elevated in patients with localized scleroderma.局限性硬皮病患者血清中可溶性白细胞介素6受体和可溶性gp130水平升高。
J Rheumatol. 2000 Aug;27(8):1917-21.
3
The interleukin-1, interleukin-2, interleukin-6 and tumour necrosis factor alpha serological levels in localised and systemic sclerosis.
Rom J Intern Med. 1998 Jul-Dec;36(3-4):251-9.
4
Increased levels of circulating intercellular adhesion molecule-1 in patients with localized scleroderma.局限性硬皮病患者循环中细胞间黏附分子-1水平升高。
J Am Acad Dermatol. 1994 Oct;31(4):591-5. doi: 10.1016/s0190-9622(94)70221-7.
5
Demonstration of interleukin-2, interleukin-4 and interleukin-6 in sera from patients with localized scleroderma.局限性硬皮病患者血清中白细胞介素-2、白细胞介素-4和白细胞介素-6的检测
Arch Dermatol Res. 1995;287(2):193-7. doi: 10.1007/BF01262331.
6
Anti-agalactosyl immunoglobulin G antibodies in localized scleroderma.局限性硬皮病中的抗半乳糖基免疫球蛋白G抗体
Int J Dermatol. 2005 Oct;44(10):817-20. doi: 10.1111/j.1365-4632.2005.02584.x.
7
Autoantibodies against matrix metalloproteinase-1 in patients with localized scleroderma.局限性硬皮病患者中抗基质金属蛋白酶-1自身抗体
J Dermatol Sci. 2008 Oct;52(1):47-54. doi: 10.1016/j.jdermsci.2008.04.013. Epub 2008 Jun 18.
8
Antinucleosome antibody is a major autoantibody in localized scleroderma.抗核小体抗体是局限性硬皮病中的一种主要自身抗体。
Br J Dermatol. 2004 Dec;151(6):1182-8. doi: 10.1111/j.1365-2133.2004.06256.x.
9
Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma.局限性硬皮病患者中的抗磷脂酰丝氨酸 - 凝血酶原复合物抗体
Clin Exp Rheumatol. 2006 Jan-Feb;24(1):19-24.
10
Clinical significance of serum matrix metalloproteinase-13 levels in patients with localized scleroderma.局限性硬皮病患者血清基质金属蛋白酶-13水平的临床意义
Clin Exp Rheumatol. 2006 Jul-Aug;24(4):394-9.

引用本文的文献

1
Use of Glucagon-Like Peptide-1 (GLP-1) Agonists in Modulating Preexisting Dermatologic Disease: A Systematic Review.胰高血糖素样肽-1(GLP-1)激动剂在调节已存在的皮肤病中的应用:一项系统评价。
Cureus. 2025 Sep 26;17(9):e93282. doi: 10.7759/cureus.93282. eCollection 2025 Sep.
2
Is adiponectin involved in morphea pathogenesis? - first observational study.脂联素是否参与硬斑病的发病机制?——首次观察性研究。
Front Immunol. 2025 May 30;16:1588439. doi: 10.3389/fimmu.2025.1588439. eCollection 2025.
3
Interleukin-13 in immunohistochemistry: implications for Grover disease, morphea, and immune checkpoint inhibitor-induced bullous pemphigoid.
免疫组织化学中的白细胞介素-13:对格罗弗病、硬斑病和免疫检查点抑制剂诱导的大疱性类天疱疮的意义。
Arch Dermatol Res. 2025 Feb 14;317(1):412. doi: 10.1007/s00403-025-03901-z.
4
Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.干扰素-γ诱导蛋白-10(IP-10)和肿瘤坏死因子-α(TNF-α)作为局限性硬皮病活动疾病状态的血清学预测指标。
Int J Mol Sci. 2024 Sep 21;25(18):10134. doi: 10.3390/ijms251810134.
5
Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?与1型相关皮肤炎症性疾病相关的2型免疫:是友还是敌?
Front Immunol. 2024 May 29;15:1405215. doi: 10.3389/fimmu.2024.1405215. eCollection 2024.
6
Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial.对硬斑病序贯脂肪移植的临床、组织学和转录组学评估:一项非随机对照试验。
JAMA Dermatol. 2024 Apr 1;160(4):425-433. doi: 10.1001/jamadermatol.2023.5908.
7
Global research status of localised scleroderma reported over the period 1993-2022: A 30-year bibliometric analysis.1993 - 2022年期间报道的局限性硬皮病全球研究现状:一项30年的文献计量分析
Int Wound J. 2024 Jan;21(1):e14559. doi: 10.1111/iwj.14559.
8
Development of Morphea Following Treatment with an ADA Biosimilar: A Case Report.阿达木单抗生物类似药治疗后发生硬斑病:1 例病例报告。
Curr Rheumatol Rev. 2024;20(4):451-454. doi: 10.2174/0115733971266803231117072453.
9
Unravelling morphoea aetiopathogenesis by next-generation sequencing of paired skin biopsies.通过对配对皮肤活检进行下一代测序来揭示硬斑病的发病机制。
Arch Dermatol Res. 2023 Sep;315(7):2035-2056. doi: 10.1007/s00403-023-02541-5. Epub 2023 Mar 13.
10
Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea.局限性硬皮病患者血清中特定白细胞介素-1家族细胞因子的水平
J Clin Med. 2022 Oct 28;11(21):6375. doi: 10.3390/jcm11216375.